A detailed history of Point72 Hong Kong LTD transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Point72 Hong Kong LTD holds 1,178 shares of MRVI stock, worth $9,023. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,178
Holding current value
$9,023
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$6.87 - $11.34 $8,092 - $13,358
1,178 New
1,178 $8,000
Q3 2022

Nov 14, 2022

BUY
$20.6 - $30.37 $64,148 - $94,572
3,114 Added 141.67%
5,312 $136,000
Q2 2022

Aug 15, 2022

SELL
$26.05 - $37.48 $63,145 - $90,851
-2,424 Reduced 52.44%
2,198 $62,000
Q1 2022

May 16, 2022

BUY
$24.46 - $40.92 $113,054 - $189,132
4,622 New
4,622 $163,000
Q3 2021

Nov 15, 2021

SELL
$36.8 - $60.62 $39,449 - $64,984
-1,072 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$32.46 - $45.0 $34,797 - $48,240
1,072 New
1,072 $45,000

Others Institutions Holding MRVI

About MARAVAI LIFESCIENCES HOLDINGS, INC.


  • Ticker MRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 131,540,000
  • Market Cap $1.01B
  • Description
  • Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...
More about MRVI
Track This Portfolio

Track Point72 Hong Kong LTD Portfolio

Follow Point72 Hong Kong LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Hong Kong LTD with notifications on news.